Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
News|Videos|October 16, 2026
Countering COVID-19 vaccine myths in pregnancy
Fact checked by: Joshua Fitch, Senior Editor
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Advertisement
Advertisement
Welcome to this Contemporary OB/GYN Special Report series on maternal immunization heading into the 2026-27 respiratory season. Across 5 episodes, our host and experts examine what the latest guidance means in practice for obstetric and pediatric clinicians and for the patients they counsel.
Related to this article
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Advertisement
Advertisement